Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Cofoe Medical Technology Co., Ltd. (1187)
Market Closed
4 Sep, 08:00 AM
HKEX
All
(1)
HK
(1)
HKEX
Primary
32.
12
HKD
+0.62
+1.9683%
HKD
6.97B
Market Cap
-
P/E Ratio
1.39%
Div Yield
62,000
Volume
-
Eps
31.5
HKD
Previous Close
Watching
Watch
Add Transaction
Day Range
31.52
32.88
Year Range
25.88
41
Want to track
1187
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Statistics
Historical Data
Cofoe Medical Technology Co., Ltd. (1187) Statistics
Valuation metrics
Market Cap
6.97B
Enterprise value
5.32B
Trailing P/E (ttm)
13.02
Forward P/E
10.12
PEG ratio
10.12
Price/Sales (ttm)
1.76
Price/Book (mrq)
1.05
Enterprise Value/Revenue
1.15
Enterprise Value/EBITDA
8.97
Overview
Shares outstanding
235.9M
Float
102.03M
Shares short
-
% Held by insiders
0.38%
% Held by institutions
0.06%
Average volume (10 days)
64.61K
Average volume (90 days)
62.01K
Price summary
52-Week low
25.88
52-Week high
41
Beta
0.6
50-Day moving average
32.83
200-Day moving average
32.03
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
30 Jun 2026
Profitability
Profit margin
0.1%
Operating margin
0.09%
Operational effectiveness
Return on assets
0.04%
Return on equity
0.08%
Income Statement
Revenue (ttm)
4.63B
Revenue per share (ttm)
19.04
Quarterly revenue growth (yoy)
0.4%
Gross profit (ttm)
2.52B
EBITDA
611.23M
Net income to common (ttm)
475.07M
Diluted EPS (ttm)
2.27
Quarterly earnings growth (yoy)
0.25%
Balance Sheet
Total cash (mrq)
3.58B
Total cash per share (mrq)
13.48
Total debt (mrq)
1.01B
Total Debt/Equity (mrq)
15.6
Current ratio (mrq)
2.63%
Book value per share (mrq)
28.24
Cash Flow
Cash flow statement
709.07M
Levered free cash flow (LFCF)
388.14M